Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 11:9:1054.
doi: 10.3389/fneur.2018.01054. eCollection 2018.

Eslicarbazepine Acetate Modulates EEG Activity and Connectivity in Focal Epilepsy

Affiliations

Eslicarbazepine Acetate Modulates EEG Activity and Connectivity in Focal Epilepsy

Giovanni Pellegrino et al. Front Neurol. .

Abstract

Introduction: Eslicarbazepine acetate (ESL) is an antiepileptic drug approved as monotherapy or add-on for the treatment of epilepsy with seizures of focal onset. ESL owns a good profile in terms of efficacy and tolerability, but its effects on EEG activity and connectivity are unknown. The purpose of this study was to investigate EEG activity and connectivity changes after ESL treatment in persons with focal epilepsy (PFE). Material and Methods: We performed a multicentre, longitudinal, retrospective, quantitative EEG study on a population of 22 PFE, and a group of 40 controls. We investigated the ESL-related changes of EEG power spectral activity and global connectivity [phase locking value (PLV), amplitude envelope correlation (AEC) and amplitude envelope correlation of orthogonalized signals (Ortho-AEC)] for standard frequency bands (delta to gamma). Seizure frequency was evaluated to assess ESL efficacy in our cohort. Results: ESL significantly enhanced both global power spectral density and connectivity for all frequency bands, similarly for all connectivity measures. When compared to the control group, Post-ESL power was significantly higher in theta and gamma band. Pre-ESL connectivity values were significantly lower than control for all frequency bands. Post-ESL connectivity increased and the gap between the two groups was no longer significant. ESL induced a 52.7 ± 41.1% reduction of seizure frequency, with 55% of clinical responders (reduction of seizures ≥50%). Discussion: ESL therapy induces significant enhancement of brain activity and connectivity. Post-ESL connectivity profile of epilepsy patients was similar to the one of healthy controls.

Keywords: EEG; antiepileptic drugs; connectivity; epilepsy; eslicarbazepine; focal epilepsy; networks; power.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Power Spectral Density (PSD) Pre and Post eslicarbazepine acetate and for the control group. PSD is expressed as average across channels. Error bars represent standard error of the mean. PSD was globally higher post-eslicarbazepine acetate than before.
Figure 2
Figure 2
Connectivity Pre and Post eslicarbazepine acetate and for the control group. Left panel shows PLV, right panel shows AEC, and AEC computed on orthogonalized data. Connectivity was higher post-eslicarbazepine acetate than before. Pre-ESL connectivity values were significantly lower than control for all frequency bands. Post-ESL connectivity increased and the gap between the two groups was no longer significant. A similar pattern was observed for all connectivity measures under investigation. *denotes p < 0.05; **denotes p < 0.001.

References

    1. Elger C, Halász P, Maia J, Almeida L, Soares-da-Silva P. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia (2009) 50:454–63. 10.1111/j.1528-1167.2008.01946.x - DOI - PubMed
    1. Gil-Nagel A, Elger C, Ben-Menachem E, Halász P, Lopes-Lima J, Gabbai AA, et al. . Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies. Epilepsia (2013) 54:98–107. 10.1111/j.1528-1167.2012.03605.x - DOI - PubMed
    1. Jacobson MP, Pazdera L, Bhatia P, Grinnell T, Cheng H, Blum D. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study. BMC Neurol. (2015) 15:46. 10.1186/s12883-015-0305-5 - DOI - PMC - PubMed
    1. Sperling MR, Harvey J, Grinnell T, Cheng H, Blum D. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America. Epilepsia (2015) 56:546–55. 10.1111/epi.12934 - DOI - PMC - PubMed
    1. Sperling MR, French J, Jacobson MP, Pazdera L, Gough M, Cheng H, et al. . Conversion to eslicarbazepine acetate monotherapy A pooled analysis of 2 phase III studies. Neurology (2016) 86:1095–102. 10.1212/WNL.0000000000002497 - DOI - PMC - PubMed